Expression patterns of transforming growth factor-beta and its receptors in gastric mucosa of patients with refractory gastric ulcer

Table 1 Characteristics of patients with gastric ulcer and the results of treatment.

No.	Age (yr)	Sex	Location	Shape	Stage2	(cm)	Stage3	(cm)	HP	Treatment
1	73	M	Antrum	Round	A1	1	-		+	Ranitidine
2	35	F	Angle	Triangle	A1	0.8	S2		+	Nizatidine
3	42	M	Body	Ovoid	A2	0.9	-		-	Ranitidine
4	61	M	Body	Ovoid	A2	1.2	-		+	Ranitidine
51	58	F	Angle	Round	A2	1.2	H1	0.6	-	Ranitidine
61	42	M	Antrum	Triangle	A1	0.8	H2	0.5	-	Nizatidine
71	51	M	Cardia	Round	A2	1.3	H1	0.7	+	Ranitidine
81	68	M	Body	Ovoid	A1	0.9	H2	0.5	+	Nizatidine
9	54	M	Angle	Round	A2	1	S2		+	Ranitidine
10	62	F	Cardia	Round	A1	1.2	-		-	Nizatidine
11	39	F	Antrum	Ovoid	H1	0.8	-		+	Nizatidine
12	71	M	Angle	Round	A2	1	S2		-	Ranitidine
131	62	F	Antrum	Triangle	A1	1.2	H2	0.6	+	Nizatidine
141	36	M	Body	Ovoid	H1	0.7	H2	0.4	-	Ranitidine
151	46	F	Angle	Round	A1	1.3	H1	0.9	+	Ranitidine
161	40	M	Antrum	Ovoid	A2	0.9	H2	0.6	+	Nizatidine

¹Poor ulcer healing. ²Ulcer stage before treatment (greatest dimension in cm). ³Ulcer stage after treatment (- means completely healed mucosa). HP: Presence or absence of Helicobacter pylori before treatment.